Mechanisms of Reovirus Bloodstream Dissemination

呼肠孤病毒血流传播机制

基本信息

  • 批准号:
    8502612
  • 负责人:
  • 金额:
    $ 10.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-02 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objective of the proposed research is to determine mechanisms by which mammalian reovirus nonstructural protein s1s promotes systemic viral dissemination. Previous studies and preliminary data indicate that the s1s protein functions in reovirus- induced cell cycle arrest and apoptosis. However, it is not known whether these processes are responsible for s1s-mediated reovirus spread in the infected host. The central hypothesis of these studies is that the s1s protein inhibits host cell cycle progression, leading to apoptotic cell death. Subsequently, apoptotic cells are engulfed by phagocytic cells that transport the virus from the site of inoculation to peripheral organs that support secondary viral replication. Two integrated specific aims are proposed to determine how s1s contributes to reovirus-induced cell cycle arrest, apoptosis, and systemic spread. The first specific aim will define sequences in s1s required for cell cycle perturbation and apoptosis induction, and identify cellular factors involved in disrupting cell cycle progression in response to reovirus infection. The second specific aim will determine the role of s1s-mediated cell cycle arrest and apoptosis in systemic reovirus dissemination in vivo. Collectively, these studies will contribute broadly to viral pathogenesis research by enhancing an understanding of the molecular and cellular bases of viral dissemination, and provide important new insights into mechanisms by which viral infection modulates the host cell cycle and culminates in disease. My near-term career goal is to obtain a position at a college or university where I will lead my own research team. I am currently applying for academic positions and hope to attain a suitable opportunity within the next academic year. I look forward to becoming an independent investigator and building my research team. I will begin by applying for research grants, including an investigator-initiated R01 application. This application for a K22 career development award has been submitted to improve the prospects of achieving both of these goals. The training I have received to this point in my career has prepared me well for the transition from postdoctoral fellow to independent laboratory team leader. This award would enhance the possibility of obtaining a tenure-track faculty position and provide funds to generate preliminary data that will form the foundation of future grant applications.
描述(由申请人提供):拟议研究的目的是确定哺乳动物呼肠孤病毒非结构蛋白s1s促进全身病毒传播的机制。先前的研究和初步数据表明s1s蛋白在呼肠孤病毒诱导的细胞周期阻滞和凋亡中起作用。然而,尚不清楚这些过程是否与s1介导的呼肠孤病毒在受感染宿主中的传播有关。这些研究的中心假设是s1s蛋白抑制宿主细胞周期进程,导致凋亡细胞死亡。随后,凋亡细胞被吞噬细胞吞噬,吞噬细胞将病毒从接种部位转运到支持病毒二次复制的外周器官。提出了两个综合的特异性目标,以确定s1s如何参与呼肠孤病毒诱导的细胞周期阻滞、细胞凋亡和全身扩散。第一个具体目标是确定s1s中干扰细胞周期和诱导细胞凋亡所需的序列,并确定呼肠孤病毒感染时参与破坏细胞周期进程的细胞因子。第二个具体目标是确定s1s介导的细胞周期阻滞和细胞凋亡在呼肠孤病毒体内全身传播中的作用。总的来说,这些研究将通过加强对病毒传播的分子和细胞基础的理解,对病毒发病机制的研究做出广泛贡献,并为病毒感染调节宿主细胞周期并最终导致疾病的机制提供重要的新见解。我近期的职业目标是在一所学院或大学获得一份工作,在那里我将领导我自己的研究团队。我目前正在申请学术职位,希望在下一学年获得合适的机会。我期待着成为一名独立的研究者,建立自己的研究团队。我将从申请研究经费开始,包括一份由研究者发起的R01申请。提交K22职业发展奖的申请是为了改善实现这两个目标的前景。在我的职业生涯中,我所接受的训练为我从博士后到独立实验室团队负责人的转变做好了准备。该奖项将增加获得终身教职的可能性,并提供资金来生成初步数据,这些数据将成为未来赠款申请的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karl W Boehme其他文献

Karl W Boehme的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karl W Boehme', 18)}}的其他基金

Reovirus induction of host inflammatory responses
呼肠孤病毒诱导宿主炎症反应
  • 批准号:
    10726153
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
Mechanisms of Reovirus Bloodstream Dissemination
呼肠孤病毒血流传播机制
  • 批准号:
    9754570
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Mechanisms of Reovirus Bloodstream Dissemination
呼肠孤病毒血流传播机制
  • 批准号:
    9237383
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Mechanisms of Reovirus Bloodstream Dissemination
呼肠孤病毒血流传播机制
  • 批准号:
    8190233
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:
Characterization of the reovirus simga 1s protien.
呼肠弧病毒 simga 1s 蛋白的表征。
  • 批准号:
    7485441
  • 财政年份:
    2008
  • 资助金额:
    $ 10.8万
  • 项目类别:
Project 4 - TLR2-mediatecl control of inflammatory arthritis
项目 4 - TLR2 介导炎症性关节炎的控制
  • 批准号:
    8523931
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Project 4 - TLR2-mediatecl control of inflammatory arthritis
项目 4 - TLR2 介导炎症性关节炎的控制
  • 批准号:
    8460762
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Project 4 - TLR2-mediatecl control of inflammatory arthritis
项目 4 - TLR2 介导控制炎症性关节炎
  • 批准号:
    8652487
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了